Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models

Steroids

Volumn 74, Issue 4-5, 2009, Pages 404-409

  Pennanen, Pasi T ^a   Sarvilinna, Nanna S ^a   Purmonen, Sami R ^a,b   Ylikomi, Timo J ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Breast cancer; Estrogen; Microarray; Progestin

Indexed keywords

COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 4; PROTEIN TYROSINE PHOSPHATASE; TRISTETRAPROLIN; TYROSINE PHOSPHATASE IV A; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

BREAST NEOPLASMS; BUTYRATE RESPONSE FACTOR 1; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTINS; PROTEIN TYROSINE PHOSPHATASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 61349141173     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.12.005     Document Type: Article

References (46)

1. Hoskins K., and Weber B.L. The biology of breast cancer. Curr Opin Oncol 6 November (6) (1994) 554-559
2. Chang K.J., Lee T.T., Linares-Cruz G., Fournier S., and de Lignieres B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 63 April (4) (1995) 785-791
3. McManus M.J., and Welsch C.W. The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 54 November (9) (1984) 1920-1927
4. van Bogaert L.J. Effect of hormone on human mammary duct in vitro. Horm Metab Res 10 July (4) (1978) 337-340
5. Laidlaw I.J., Clarke R.B., Howell A., Owen A.W., Potten C.S., and Anderson E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136 January (1) (1995) 164-171
6. Gompel A., Malet C., Spritzer P., Lalardrie J.P., Kuttenn F., and Mauvais-Jarvis P. Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63 November (5) (1986) 1174-1180
7. Ruedl C., Cappelletti V., Coradini D., Granata G., and Di Fronzo G. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells. J Steroid Biochem Mol Biol 37 October (2) (1990) 195-200
8. Katzenellenbogen B.S., Kendra K.L., Norman M.J., and Berthois Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47 August (16) (1987) 4355-4360
9. Berthois Y., Katzenellenbogen J.A., and Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83 April (8) (1986) 2496-2500
10. Brunner N., Bronzert D., Vindelov L.L., Rygaard K., Spang-Thomsen M., and Lippman M.E. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49 March (6) (1989) 1515-1520
11. Huseby R.A., Maloney T.M., and McGrath C.M. Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vivo. Cancer Res 44 June (6) (1984) 2654-2659
12. Kyprianou N., English H.F., Davidson N.E., and Isaacs J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51 January (1) (1991) 162-166
13. Shafie S.M., and Grantham F.H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67 July (1) (1981) 51-56
14. Topper Y.J., and Freeman C.S. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60 October (4) (1980) 1049-1106
15. Gill P.G., Vignon F., Bardon S., Derocq D., and Rochefort H. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells. Breast Cancer Res Treat 10 October (1) (1987) 37-45
16. Kester H.A., van der Leede B.M., van der Saag P.T., and van der Burg B. Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem 272 June (26) (1997) 16637-16643
17. Lippert C., Seeger H., Wallwiener D., and Mueck A.O. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment. Eur J Gynaecol Oncol 22 5 (2001) 331-335
18. Schoonen W.G., Joosten J.W., and Kloosterboer H.J. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. J Steroid Biochem Mol Biol 55 December (3-4) (1995) 423-437
19. Schoonen W.G., Joosten J.W., and Kloosterboer H.J. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II.T47D cell lines. J Steroid Biochem Mol Biol 55 3-4 (1995 Dec) 439-444
20. Seeger H., Wallwiener D., and Mueck A.O. Comparison of the effect of progesterone, medroxyprogesterone acetate and norethisterone on the proliferation of human breast cancer cells. J Br Menopause Soc 9 March (1) (2003) 36-38
21. Seeger H., Wallwiener D., and Mueck A.O. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Horm Metab Res 35 February (2) (2003) 76-80
22. Sutherland R.L., Hall R.E., Pang G.Y., Musgrove E.A., and Clarke C.L. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res 48 September (18) (1988) 5084-5091
23. Vignon F., Bardon S., Chalbos D., and Rochefort H. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. J Clin Endocrinol Metab 56 June (6) (1983) 1124-1130
24. Bentel J.M., Birrell S.N., Pickering M.A., Holds D.J., Horsfall D.J., and Tilley W.D. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol Cell Endocrinol 154 August (1-2) (1999) 11-20
25. Poulin R., Baker D., Poirier D., and Labrie F. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids. Breast Cancer Res Treat 17 January-February (3) (1991) 197-210
26. Hackenberg R., Hawighorst T., Filmer A., Nia A.H., and Schulz K.D. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. Breast Cancer Res Treat 25 3 (1993) 217-224
27. Poulin R., Baker D., Poirier D., and Labrie F. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat 13 March (2) (1989) 161-172
28. Kontula K., Paavonen T., Luukkainen T., and Andersson L.C. Binding of progestins to the glucocorticoid receptor, correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol 32 May (9) (1983) 1511-1518
29. Selman P.J., Wolfswinkel J., and Mol J.A. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids 61 March (3) (1996) 133-137
30. Sarvilinna N., Eronen H., Miettinen S., Vienonen A., and Ylikomi T. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells. Int J Cancer 118 February (4) (2006) 832-840
31. Kueng W., Silber E., and Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 182 October (1) (1989) 16-19
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 May (9) (2001) e45
33. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., and Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277 February (7) (2002) 5209-5218
34. Wan Y., and Nordeen S.K. Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells. Mol Endocrinol 16 June (6) (2002) 1204-1214
35. Purmonen S., Ahola T.M., Pennanen P., Aksenov N., Zhuang Y.H., Tuohimaa P., et al. HDLG5/KIAA0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells. Int J Cancer 102 November (1) (2002) 1-6
36. Carrick D.M., and Blackshear P.J. Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys 462 June (2) (2007) 278-285
37. Abba M.C., Sun H., Hawkins K.A., Drake J.A., Hu Y., Nunez M.I., et al. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 5 September (9) (2007) 881-890
38. Diamond R.H., Cressman D.E., Laz T.M., Abrams C.S., and Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol 14 June (6) (1994) 3752-3762
39. Diamond R.H., Peters C., Jung S.P., Greenbaum L.E., Haber B.A., Silberg D.G., et al. Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. Am J Physiol 271 July (1 Pt 1) (1996) G121-G129
40. Cates C.A., Michael R.L., Stayrook K.R., Harvey K.A., Burke Y.D., Randall S.K., et al. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett 110 December (1-2) (1996) 49-55
41. Wang J., Kirby C.E., and Herbst R. The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis. J Biol Chem 277 November (48) (2002) 46659-46668
42. Xu X., Murdoch F.E., Curran E.M., Welshons W.V., and Fritsch M.K. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression. Gene 328 March (2004) 143-151
43. Vienonen A., Syvala H., Miettinen S., Tuohimaa P., and Ylikomi T. Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines. J Steroid Biochem Mol Biol 80 March (3) (2002) 307-313
44. Krishnan A.V., Swami S., and Feldman D. Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 77 April (1) (2001) 29-37
45. Vienonen A., Miettinen S., Manninen T., Altucci L., Wilhelm E., and Ylikomi T. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines. Eur J Endocrinol 148 April (4) (2003) 469-479
46. Campagnoli C., Clavel-Chapelon F., Kaaks R., Peris C., and Berrino F. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol 96 July (2) (2005) 95-108